Advertisement

ACS CAN: Executive order on pre-existing condition protections unlikely to help cancer patients and survivors

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

As part of a broader health care package, the Trump administration Sept. 24 issued an executive order to preserve health coverage protections for people with pre-existing conditions should the Supreme Court invalidate the Affordable Care Act.

A statement from Lisa Lacasse, president of the American Cancer Society Cancer Action Network follows:

“The executive order on pre-existing conditions falls far short of the protections already in place under the Affordable Care Act. The ACA’s rules against insurance denials or sky-high premiums based on someone’s health history have, for the last decade, been an essential lifeline to millions of American cancer patients and survivors.

“These patients cannot go back to a world wherein their ability to access lifesaving treatment is tied to an insurance market that is again allowed to restrict, rescind or reject their care. Should the administration succeed in its case to throw out the law, the executive order will offer no guaranteed patient protections in its place.”

Advertisement
Advertisement
Table of Contents
Advertisement
Advertisement

YOU MAY BE INTERESTED IN

In an effort to target the right patients, genetic screening is becoming more common in clinical trials. But incorporating it can be complex and add a significant burden for both patients and clinical trial sites. Genetic counseling can streamline that process and help drug and gene therapy developers expedite the recruitment of genetically-eligible participants for their trials and use genetic testing results to accelerate the speed and success of clinical trials.
Advertisement
Advertisement